Vita Therapeutics (Series B)
Funding Details
Awarder
Inbox
Date Award
October 12, 2022
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$31,000,000
Company Info
Traction
The company is currently working with numerous partners, including PanCella, Wyss Institute, and Johns Hopkins University, to advance their clinical programs.
Organizations Involved
PanCella, Wyss Institute, Johns Hopkins University
Founders
Douglas Falk
Market
Cellular therapeutics for neuromuscular diseases and cancers
Location
Baltimore, MD, USA
Coinvestors
Cambrian Biopharma, Cedars-Sinai Medical Center, Riptide Ventures, Solve FSHD, TEDCO
Company Description

Vita Therapeutics is a cell engineering company that develops life-transformative treatments.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Biotechnology DealsView Funding Announcement